Skip to main content
SpringerLink
Log in

Economists propose a US$30 billion boost to biomedical R&D

  • News and Analysis
  • Published:

From Nature Reviews Drug Discovery

View current issue Sign up to alerts

Economists hope they can attract billions of dollars for drug R&D by securitizing research projects. Could they close the innovation gap in the process?

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Authors
  1. Asher Mullard
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mullard, A. Economists propose a US$30 billion boost to biomedical R&D. Nat Rev Drug Discov 11, 735–737 (2012). https://doi.org/10.1038/nrd3857

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrd3857

  • Springer Nature Limited

Search

Navigation